UBS Maintains Buy on Elanco Animal Health, Raises Price Target to $33

Benzinga Newsdesk www.benzinga.com Positive 85.3%

Neg 0% Neu 0% Pos 85.3%

UBS analyst Andrea Alfonso maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $31 to $33.